Monte Rosa Therapeutics, Inc. (GLUE) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$19.05
-1.24%
Mkt Cap $1.31B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | $15.55M | $2.80M | -82.00% | -$0.35 | -$0.54 | -53.61% | — | — |
| Q4 2025 Nov 6, 2025 | $15.51M | $12.77M | -17.66% | -$0.37 | -$0.33 | +9.92% | — | — |
| Q3 2025 Aug 7, 2025 | $7.77M | $23.19M | +198.37% | -$0.38 | -$0.15 | +60.19% | — | — |
| Q2 2025 May 8, 2025 | $13.57M | $84.93M | +526.01% | -$0.00 | $0.57 | +21690.91% | — | — |
| Q1 2025 Mar 20, 2025 | $46.67M | $60.65M | +29.95% | $0.02 | $0.23 | +1379.10% | — | — |
| Q4 2024 Nov 7, 2024 | $2.64M | $9.22M | +249.34% | -$0.49 | -$0.29 | +40.82% | — | — |
| Q3 2024 Aug 8, 2024 | $1.35M | $4.70M | +248.07% | -$0.54 | -$0.43 | +20.37% | — | — |
| Q2 2024 May 9, 2024 | $1.40M | $1.06M | -24.00% | -$0.57 | -$0.53 | +7.02% | — | — |
| Q1 2024 Mar 14, 2024 | $3.53M | — | — | -$0.33 | -$0.58 | -75.76% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.72 | -$0.70 | +2.78% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.70 | -$0.71 | -1.43% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.68 | -$0.65 | +4.41% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.62 | -$0.63 | -1.61% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.60 | -$0.58 | +3.33% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.54 | -$0.57 | -5.56% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$0.52 | -$0.51 | +1.92% | — | — |
| Q1 2022 Mar 29, 2022 | — | — | — | -$0.50 | -$0.93 | -86.00% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.44 | -$0.43 | +2.27% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.40 | -$3.63 | -807.50% | — | — |
| Q2 2021 Jun 25, 2021 | — | — | — | — | -$0.29 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.90 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.30 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.25 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.20 | — | — | — |